Sufentanil alleviates pre-eclampsia via silencing microRNA-24-3p to target 11β-Hydroxysteroid dehydrogenase type 2

References

• Ives CW, Sinkey R, Rajapreyar I, et al. Preeclampsia—pathophysiology and clinical presentations: JACC state-of-the-art review. J Am Coll Cardiol. 2020;76(14):1690–1702.
   PubMed Web of Science ®Google Scholar
• Lv Y, Lu C, Ji X, et al. Roles of microRNAs in preeclampsia. J Cell Physiol. 2019;234(2):1052–1061.
   PubMed Web of Science ®Google Scholar
• Motawi TM, Sabry D, Maurice NW, et al. Role of mesenchymal stem cells exosomes derived microRNAs; miR-136, miR-494 and miR-495 in pre-eclampsia diagnosis and evaluation. Arch Biochem Biophys. 2018;659:13–21.
   PubMed Web of Science ®Google Scholar
• Ding H, Dai Y, Lei Y, et al. Upregulation of CD81 in trophoblasts induces an imbalance of Treg/Th17 cells by promoting IL-6 expression in preeclampsia. Cell Mol Immunol. 2019;16(3):302–312.
   PubMed Web of Science ®Google Scholar
• Porela-Tiihonen S, Kokki H, Kokki M. An up-to-date overview of sublingual sufentanil for the treatment of moderate to severe pain. Expert Opin Pharmacother. 2020;21(12):1407–1418.
   PubMed Web of Science ®Google Scholar
• Zhou L, Yang X, Shu S, et al. Sufentanil protects the liver from ischemia/reperfusion-induced inflammation and apoptosis by inhibiting ATF4-induced TP53BP2 expression. Inflammation. 2021;44(3):1160–1174.
   PubMed Web of Science ®Google Scholar
• Wu Q, Shang Y, Bai Y, et al. Sufentanil preconditioning protects against myocardial ischemia/reperfusion injury via miR-125a/DRAM2 axis. Cell Cycle. 2021;20(4):383–391.
   PubMed Web of Science ®Google Scholar
• Li L, Sun Y, Zhang N, et al. By regulating miR-182-5p/BCL10/CYCS, sufentanil reduces the apoptosis of umbilical cord mesenchymal stem cells caused by ropivacaine. Biosci Trends. 2019;13(1):49–57.
   PubMed Web of Science ®Google Scholar
• Malvasi A, Tinelli A, Brizzi A, et al. Long-term epidural analgesia treatment in pre-eclamptic women: a preliminary trial. J Obstetrics Gynaecol. 2009;29(2):114–118.
   PubMedGoogle Scholar
• Eskandari F, Rezaei M, Mohammadpour-Gharehbagh A, et al. The association of pri-miRNA-26a1 rs7372209 polymorphism and preeclampsia susceptibility. Ann Clin Exp Hypertens. 2019;41(3):268–273.
   Google Scholar
• Ye J, Xu M, Tian X, et al. Research advances in the detection of miRNA. J Pharm Anal. 2019;9(4):217–226.
   PubMed Web of Science ®Google Scholar
• Friedman RC, Farh KK-H, Burge CB, et al. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009;19(1):92–105.
   PubMed Web of Science ®Google Scholar
• Low SS, Ji D, Chai WS, et al. Recent progress in nanomaterials modified electrochemical biosensors for the detection of microRNA. Micromachines. 2021;12(11):1409.
   PubMed Web of Science ®Google Scholar
• Hornakova A, Kolkova Z, Holubekova V, et al. Diagnostic potential of MicroRNAs as biomarkers in the detection of preeclampsia. Genet Test Mol Biomarkers. 2020;24(6):321–327.
   PubMed Web of Science ®Google Scholar
• Hromadnikova I, Kotlabova K, Hympanova L, et al. Gestational hypertension, preeclampsia and intrauterine growth restriction induce dysregulation of cardiovascular and cerebrovascular disease associated microRNAs in maternal whole peripheral blood. Thromb Res. 2016;137:126–140.
   PubMed Web of Science ®Google Scholar
• Y-h L, Fang J, H-d Z, et al. Sufentanil preconditioning protects against hepatic ischemia-reperfusion injury by suppressing inflammation. Med Sci Monit. 2019;25:2265.
   PubMed Web of Science ®Google Scholar
• Xing Z, Zhang Z, Gao Y, et al. The lncRNA LINC01194/miR-486-5p axis facilitates malignancy in Non-Small cell lung cancer via regulating CDK4. Onco Targets Ther. 2020;13:3151–3163.
   PubMed Web of Science ®Google Scholar
• Yang Q, Zheng M, Yan J, et al. Rhynchophylline improves trophocyte mobility potential by upregulating ZEB1 level via the inhibition of miR-141-3p level. Biosci Biotechnol Biochem. 2021;85(2):280–286.
   PubMed Web of Science ®Google Scholar
• Han Y-W, Yang Z, Ding X-Y, et al. Differences in liver injury and trophoblastic mitochondrial damage in different preeclampsia-like mouse models. Chin Med J (Engl). 2015;128(12):1627–1635.
   PubMed Web of Science ®Google Scholar
• Xiang B, Yang J, Lei X, et al. Adjuvant sufentanil decreased the EC50 of epidural ropivacaine for labor analgesia in healthy term pregnancy. Drug Des Devel Ther. 2021;15:2143.
   PubMed Web of Science ®Google Scholar
• Bhakta P, Mishra P, Bakshi A, et al. Case report and mini literature review: anesthetic management for severe peripartum cardiomyopathy complicated with preeclampsia using sufetanil in combined spinal epidural anesthesia. Yonsei Med J. 2011;52(1):1–12.
   PubMed Web of Science ®Google Scholar
• Aya AG, Mangin R, Vialles N, et al. Patients with severe preeclampsia experience less hypotension during spinal anesthesia for elective cesarean delivery than healthy parturients: a prospective cohort comparison. Anesthesia Analg. 2003;97(3):867–872.
   PubMed Web of Science ®Google Scholar
• Gao Q, Chang N, Liu D. In vitro and in vivo assessment of the protective effect of sufentanil in acute lung injury. J Int Med Res. 2021;49(2):0300060520986351.
   PubMed Web of Science ®Google Scholar
• Hromadnikova I, Kotlabova K, Krofta L. Association analysis in young and middle-aged mothers—relation between expression of cardiovascular disease associated microRNAs and abnormal clinical findings. J Pers Med. 2021;11(1):39.
   PubMed Web of Science ®Google Scholar
• Akgör U, Ayaz L, Cayan F. Expression levels of maternal plasma microRNAs in preeclamptic pregnancies. J Obstetrics Gynaecol. 2021;41(6):910–914.
   PubMedGoogle Scholar
• Zheng H-T, Fu T, Zhang H-Y, et al. Progesterone-regulated Hsd11b2 as a barrier to balance mouse uterine corticosterone. J Endocrinol. 2020;244(1):177–187.
   PubMed Web of Science ®Google Scholar
• Shu Q, Li W, Li J, et al. Cross-talk between cAMP and MAPK pathways in HSD11B2 induction by hCG in placental trophoblasts. PLoS One. 2014;9(9):e107938.
   PubMed Web of Science ®Google Scholar
• Vasku M, Kleine-Eggebrecht N, Rath W, et al. Apparent systemic 11ß-dehydroxysteroid dehydrogenase 2 activity is increased in preeclampsia but not in intrauterine growth restriction. Pregnancy Hypertens. 2018;11:7–11.
   PubMed Web of Science ®Google Scholar
• Hu W, Weng X, Dong M, et al. Alteration in methylation level at 11β-hydroxysteroid dehydrogenase type 2 gene promoter in infants born to preeclamptic women. BMC Genet. 2014;15(1):1–6.
   PubMedGoogle Scholar